{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:49:02Z","timestamp":1792435742556,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1007\/s10620-005-3000-3","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T02:02:14Z","timestamp":1129860134000},"page":"2009-2018","source":"Crossref","is-referenced-by-count":42,"title":["Efficacy of Rabeprazole in the Treatment of Symptomatic Gastroesophageal Reflux Disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Peter J.","family":"Kahrilas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Johanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Jokubaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"3000_CR1","unstructured":"A Gallup Organization National Survey: Heartburn across America. Princeton, NJ, Gallup Organization, 1988"},{"key":"3000_CR2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke 3rd","year":"1997","unstructured":"Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112:1448\u20131456, 1997","journal-title":"Gastroenterology"},{"key":"3000_CR3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3109\/00365529709011212","volume":"32","author":"T Lind","year":"1997","unstructured":"Lind T, Havelund T, Carlsson R, et al.: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 32:974\u2013979, 1997","journal-title":"Scand J Gastroenterol"},{"key":"3000_CR4","first-page":"149","volume":"1","author":"T Jones","year":"1997","unstructured":"Jones T: Can we alter the cytokine balance in the management of infectious diseases? Braz J Infect Dis 1:149\u2013150, 1997","journal-title":"Braz J Infect Dis"},{"key":"3000_CR5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1046\/j.1365-2036.1997.00185.x","volume":"11","author":"JP Galmiche","year":"1997","unstructured":"Galmiche JP, Barthelemy P, Hamelin B: Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 11:765\u2013773, 1997","journal-title":"Aliment Pharmacol Ther"},{"key":"3000_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2036.1997.tb00798.x","volume":"22","author":"AJ Smout","year":"1997","unstructured":"Smout AJ: Endoscopy-negative acid reflux disease. Aliment Pharmacol Ther 22:81\u201385, 1997","journal-title":"Aliment Pharmacol Ther"},{"key":"3000_CR7","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/j.1572-0241.1999.01206.x","volume":"94","author":"T Havelund","year":"1999","unstructured":"Havelund T, Lind T, Wiklund I, et al.: Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol 94:1782\u20131789, 1999","journal-title":"Am J Gastroenterol"},{"key":"3000_CR8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(97)00354-9","volume":"104","author":"DA Revicki","year":"1998","unstructured":"Revicki DA, Wood M, Maton PN, Sorensen S: The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104:252\u2013258, 1998","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"3000_CR9","first-page":"II31","volume":"45","author":"RE Clouse","year":"1999","unstructured":"Clouse RE, Richter JE, Heading RC, Janssens J, Wilson JA: Functional esophageal disorders. Gut 45(Suppl 2):II31\u2013II36, 1999","journal-title":"Gut"},{"key":"3000_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/00365521.1990.12067095","volume":"25","author":"AA Masclee","year":"1990","unstructured":"Masclee AA, de Best AC, de Graaf R, Cluysenaer OJ, Jansen JB: Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 25:225\u2013230, 1990","journal-title":"Scand J Gastroenterol"},{"key":"3000_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01536157","volume":"34","author":"S Mattioli","year":"1989","unstructured":"Mattioli S, Pilotti V, Spangaro M, et al.: Reliability of 24-hour home esophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 34:71\u201378, 1989","journal-title":"Dig Dis Sci"},{"key":"3000_CR12","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/BF01536707","volume":"34","author":"F Baldi","year":"1989","unstructured":"Baldi F, Ferrarini F, Longanesi A, Ragazzini M, Barbara L: Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci 34:1890\u20131893, 1989","journal-title":"Dig Dis Sci"},{"key":"3000_CR13","first-page":"358","volume":"83","author":"GJ Wiener","year":"1988","unstructured":"Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO: The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 83:358\u2013361, 1988","journal-title":"Am J Gastroenterol"},{"key":"3000_CR14","first-page":"160","volume":"86","author":"R Breumelhof","year":"1991","unstructured":"Breumelhof R, Smout AJ: The symptom sensitivity index: a valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 86:160\u2013164, 1991","journal-title":"Am J Gastroenterol"},{"key":"3000_CR15","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0016-5085(94)90815-X","volume":"107","author":"BL Weusten","year":"1994","unstructured":"Weusten BL, Roelofs JM, Akkermans LM, Van Berge-Henegouwen GP, Smout AJ: The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 107:1741\u20131745, 1994","journal-title":"Gastroenterology"},{"key":"3000_CR16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2036.1998.00418.x","volume":"12","author":"MP Williams","year":"1998","unstructured":"Williams MP, Sercombe J, Hamilton MI, Pounder RE: A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 12:1079\u20131089, 1998","journal-title":"Aliment Pharmacol Ther"},{"key":"3000_CR17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1023\/A:1018822532736","volume":"43","author":"ML Cloud","year":"1998","unstructured":"Cloud ML, Enas N, Humphries TJ, Bassion S: Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group. Dig Dis Sci 43:993\u20131000, 1998","journal-title":"Dig Dis Sci"},{"key":"3000_CR18","first-page":"49","volume":"13","author":"CP Dekkers","year":"1999","unstructured":"Dekkers CP, Beker JA, Thjodleifsson B, Gabryelewicz A, Bell NE, Humphries TJ: Double-blind comparison [correction of Double-blind, placebo-controlled comparison] of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther 13:49\u201357, 1999","journal-title":"omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease. The European Rabeprazole Study Group. Aliment Pharmacol Ther"},{"key":"3000_CR19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1023\/A:1005548318996","volume":"45","author":"B Thjodleifsson","year":"2000","unstructured":"Thjodleifsson B, Beker JA, Dekkers C, Bjaaland T, Finnegan V, Humphries TJ: Rabeprazole versus omeprazole in preventing relapse of erosive or ulcerative gastroesophageal reflux disease: a double-blind, multicenter, European trial. The European Rabeprazole Study Group. Dig Dis Sci 45:845\u2013853, 2000","journal-title":"Dig Dis Sci"},{"key":"3000_CR20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1572-0241.2002.05769.x","volume":"97","author":"P Miner Jr","year":"2002","unstructured":"Miner P Jr, Orr W, Filippone J, Jokubaitis L, Sloan S: Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Am J Gastroenterol 97:1332\u20131339, 2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl","key":"3000_CR21","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0002-9270(01)02777-0","volume":"96","author":"J Johanson","year":"2001","unstructured":"Johanson J, Miner P, Jokubaitis L, Mao L, Sloan S: Rabeprazole significantly improves heartburn vs placebo in endoscopically negative GERD patients with moderate to severe symptoms [abstract]. Am J Gastroenterol 96(Suppl):S18, 2001","journal-title":"Am J Gastroenterol"},{"key":"3000_CR22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2036.1996.44186000.x","volume":"10","author":"CM Bate","year":"1996","unstructured":"Bate CM, Griffin SM, Keeling PW, et al.: Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis. Aliment Pharmacol Ther 10:547\u2013555, 1996","journal-title":"Aliment Pharmacol Ther"},{"key":"3000_CR23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000016970","volume":"18","author":"M Storr","year":"2000","unstructured":"Storr M, Meining A, Allescher HD: Pathophysiology and pharmacological treatment of gastroesophageal reflux disease. Dig Dis 18:93\u2013102, 2000","journal-title":"Dig Dis"},{"key":"3000_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1098-3597(99)90085-6","volume":"1","author":"AH Soll","year":"1999","unstructured":"Soll AH, Fass R: Gastroesophageal reflux: practical management of a common, challenging disorder. Clin Cornerstone 1:1\u201317, 1999","journal-title":"Clin Cornerstone"},{"key":"3000_CR25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1365-2036.1997.00181.x","volume":"11","author":"R Lambert","year":"1997","unstructured":"Lambert R: Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 11:651\u2013662, 1997","journal-title":"Aliment Pharmacol Ther"},{"key":"3000_CR26","first-page":"577","volume":"7","author":"JW Freston","year":"1995","unstructured":"Freston JW, Malagelada JR, Petersen H, McCloy RF: Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 7:577\u2013586, 1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3000_CR27","doi-asserted-by":"crossref","unstructured":"Sanders SW: Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents. Clin Ther 18:2\u201334, 31, 1996","DOI":"10.1016\/S0149-2918(96)80175-5"},{"key":"3000_CR28","doi-asserted-by":"crossref","unstructured":"Bruley des Varannes S, Galmiche JP: Evaluation of Esophageal Sensitivity, vol. 22. Basel, Karger, 1994","DOI":"10.1159\/000421788"},{"key":"3000_CR29","unstructured":"Pehlivanov N, Liu J, Mittal R: Sustained esophageal contraction: a motor correlate of heartburn symptom [abstract # G4613]. Gastroenterology 116:1999"},{"key":"3000_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gut.37.1.7","volume":"37","author":"KC Trimble","year":"1995","unstructured":"Trimble KC, Pryde A, Heading RC: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 37:7\u201312, 1995","journal-title":"Gut"},{"key":"3000_CR31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/gut.49.5.624","volume":"49","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Lembo A, Elashoff JD, Fass R, Mayer EA: Duodenal fat intensifies the perception of heartburn. Gut 49:624\u2013628, 2001","journal-title":"Gut"},{"key":"3000_CR32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00042737-199802000-00004","volume":"10","author":"R Carlsson","year":"1998","unstructured":"Carlsson R, Dent J, Watts R, et al: Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur J Gastroenterol Hepatol 10:119\u2013124, 1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3000_CR33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2036.2003.01771.x","volume":"18","author":"PO Katz","year":"2003","unstructured":"Katz PO, Castell DO, Levine D: Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther 18:875\u2013882, 2003","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3000-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-3000-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-3000-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T05:22:39Z","timestamp":1706678559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-3000-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["3000"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-3000-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}